On Monday, CorMedix Inc (NASDAQ: CRMD) opened higher 7.36% from the last session, before settling in for the closing price of $8.29. Price fluctuations for CRMD have ranged from $2.57 to $8.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -47.11% over the past five years. Company’s average yearly earnings per share was noted 31.43% at the time writing. With a float of $54.85 million, this company’s outstanding shares have now reached $54.94 million.
Let’s look at the performance matrix of the company that is accounted for 82 employees.
CorMedix Inc (CRMD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CorMedix Inc is 1.81%, while institutional ownership is 30.57%. The most recent insider transaction that took place on Mar 13 ’24, was worth 50,718. In this transaction Chief Executive Officer of this company bought 13,561 shares at a rate of $3.74, taking the stock ownership to the 352,839 shares. Before that another transaction happened on Dec 14 ’23, when Company’s Director bought 3,000 for $3.45, making the entire transaction worth $10,350. This insider now owns 12,250 shares in total.
CorMedix Inc (CRMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 31.43% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Check out the current performance indicators for CorMedix Inc (CRMD). In the past quarter, the stock posted a quick ratio of 4.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 613.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 0.04 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
CorMedix Inc (NASDAQ: CRMD) saw its 5-day average volume 0.74 million, a positive change from its year-to-date volume of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 90.14%. Additionally, its Average True Range was 0.44.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 97.60%, which indicates a significant increase from 94.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.89% in the past 14 days, which was lower than the 69.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.95, while its 200-day Moving Average is $4.71. Nevertheless, the first resistance level for the watch stands at $9.19 in the near term. At $9.49, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.94. If the price goes on to break the first support level at $8.44, it is likely to go to the next support level at $7.99. The third support level lies at $7.69 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
There are currently 54,959K shares outstanding in the company with a market cap of 497.15 million. Presently, the company’s annual sales total 0 K according to its annual income of -46,340 K. Last quarter, the company’s sales amounted to 810 K and its income totaled -14,150 K.
